Skip to main content
Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

6 wyświetleń
Pobierz
Farmaceutyczny

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Moc

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Wielkość opakowania

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Postać

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Skutki uboczne

Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Powiązane artykuły kliniczne

Skanuj ten kod QR, aby szybko uzyskać dostęp do tej strony na swoim urządzeniu mobilnym.

QR Code